Navigation Links
Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
Date:3/4/2009

SOUTH EASTON, Mass., March 4 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI" or the "Company") today announced that total revenue for the fourth quarter of 2008 was $334,041 compared to $174,071 for the comparable period in 2007, a 92% increase. Revenue from the sale of PCT products and services was $233,256 for the three months ended December 31, 2008 compared to $118,703 for the same period in 2007, a 97% increase. During the fourth quarter of 2008, the Company completed the installation of ten Barocycler instruments, as compared to seven during the same period of 2007. Eight of the ten were domestic installations and two were international sales, compared to three domestic installations and four international sales for the same quarter in 2007.

Operating loss for the fourth quarter of 2008 was $900,100 compared to $1,297,975 for the same period in 2007, a decrease of $(397,875) or 30%. This decrease in operating loss was primarily related to the Company's restructuring program announced on December 1, 2008, the cost containment initiatives that the Company instituted during the second and third quarters of 2008, and the record revenues of the 2008 fourth quarter. The Company currently expects its operating loss to continue to decrease to an average of less than $600,000 per quarter during 2009.

As the Company is completing its annual financial reporting and auditing process, the revenue and operating numbers mentioned in this release are unaudited.

Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. said: "The fourth quarter of 2008 was extremely difficult for PBI. Faced with a very tough economic climate and decreasing cash, we made the difficult decision to significantly restructure the Company. Changes related to the restructuring program included a reductio
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
2. Pressure BioSciences, Inc. Issued First Patent in Canada
3. Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
4. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
5. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
6. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
7. Pressure BioSciences, Inc. Provides Corporate Update
8. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
9. The sensitive side of carbon nanotubes: Creating powerful pressure sensors
10. FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children
11. Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Shire plc (LSE: SHP,NA...ical company, today,announced that it has submitte...lucerase alfa, the company,s enzyme replacement th...aucher disease. This is the third marketing,applic...ed, with previous,submissions in the United States...
(Date:11/24/2009)...Nov. 24 Genomic Health, ...cott, Genomic Health,s Executive Chairman, will pr... Conference in New York City on Tuesday, December ...e and subsequently archived webcast of the present...omic Health,s website at http://investor.genomich...
(Date:11/24/2009)...nnects Customers with Partners Validated to Proces...roducts , Ottawa, ON (PRW...provider of products for biological sample collect...d its new global partner program. The program offe...ner community and is designed to help partners sca...
(Date:11/24/2009)...Newswire-FirstCall/ -- Cell Therapeutics, Inc. (CT...at the 21st Annual Piper Jaffray Health Care Confe...009, at the New York Palace Hotel. ,, CTI wil...tern Time in Holmes 1 (4th Floor). A live audio we...www.celltherapeutics.com , and it will also be ava...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...Inc.,(Nasdaq: BHRT ) today announced that it has ...ommon stock to the Nasdaq Capital Market. The Comp...sdaq Global Market to The,Nasdaq Capital Market at...8. The Nasdaq Capital Market is a tier of the Nasd...capitalization requirement than the Global,Market ...
...0 Miltenyi Biotec has,acquired Medic Tools AG fro... Biotec strengthens the portfolio in the area of s...y devices and techniques fit,perfectly into the pr...,offered by Miltenyi Biotec", Miltenyi Biotec CEO ...ent and CEO of Medic Tools AG, stated in a,conjoin...
... for The Joint,Commission survey process within th...virtually all internal services used to support pa...audited. As a result, a,healthcare institution mus...proceed in almost any direction and to involve any...iew sessions, if done properly, can dramatically,i...
Other Biology Technology:Bioheart, Inc. to Transfer to Nasdaq Capital Market 2Miltenyi Biotec GmbH Acquires Medic Tools AG 2White Paper Helps Hospitals Prepare Staff for Joint Commission Environment of Care Interview Sessions 2
(Date:11/23/2009)... Farmington, CT Current research suggests that a ...sease. The related report by Nichols et al, "Uniq...a New Class of TLR2 Ligands Capable of Enhancing A...f The American Journal of Pathology . , Multipl...m attacks the brain and spinal cord, affects nearl...
(Date:11/23/2009)..., AMES, Iowa - The only swine vaccine available f...ne herd infected with the virus. The vaccination m...ne herd diagnosed with the pandemic flu., Iowa S... science, developed the vaccine this summer and ha...s in Iowa, Kansas and Illinois for several weeks.,...
(Date:11/23/2009)... MADISON, WI, November 16, 2009 -- A USDOE and USD...opland, idle cropland, and cropland pasture could ...f perennial grasses, such as switchgrass, from whi... feedstock. Economically viable production of a pe...uantities of biomass are removed annually is expec...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Researchers Present a Novel Automated Efficient Environmental Disinfection Technology that Significantly Reduces C difficile VRE and MRSA Contamin 14436 1Researchers Present a Novel Automated Efficient Environmental Disinfection Technology that Significantly Reduces C difficile VRE and MRSA Contamin 14436 2Researchers Present a Novel Automated Efficient Environmental Disinfection Technology that Significantly Reduces C difficile VRE and MRSA Contamin 14436 3China Pharma Holdings Inc to Present at the Roth China Conference on October 14 at 12 3A00 pm ET 14434 1Sequella Obtains Funding to Continue Expansion of its Anti infectives Pipeline 14432 1Sequella Obtains Funding to Continue Expansion of its Anti infectives Pipeline 14432 2Sequella Obtains Funding to Continue Expansion of its Anti infectives Pipeline 14432 3
...netic changes in bacteria may ultimately help drug...ria that can become resistant to antibiotics. , Th... ribosome, a tiny protein-making factory residing ...ics alter a ribosome,s ability to make proteins, s...ant professor of microbiology at Ohio State Univer...
...rice of having one,s personal genome sequenced jus... about $2.2 million, and the goal is to reduce the...alized prevention and treatment realistic. , The s...y developed by Harvard Medical School (HMS) resear..., and their colleagues, reported on August 4 in th...
... protein in different subtypes of avian flu viruse...tadine in H5N1 occurs worldwide, but is especially...stance to the antiviral drug amantadine is spreadi...5N1 subtype in Southeast Asia than in North Americ... St. Jude Children,s Research Hospital. , The St....
Other Biology News:Study findings offer potential new targets for antibiotics 2A step toward the $1,000 personal genome using readily available lab equipment 2Drug resistant avian influenza viruses more common in Southeast Asia than North America 2Drug resistant avian influenza viruses more common in Southeast Asia than North America 3Drug resistant avian influenza viruses more common in Southeast Asia than North America 4
Human Phospho-MAPK Array Kit from R&D Systems
...lone d1-174 GenBank Accession Number : NM_006225 ...sion protein corresponding to full length rat PLC ...15M NaCl, 0.05% sodium azide before the addition o...luated by immunoblot on RIPA lysates from PC-12 ce...
Rat CXCL7 (NAP-2) ELISA development Kit, DuoSet Economy Pack from R&D Systems
Rat Fas, Unconjugated from R&D Systems
Biology Products: